Related Experiment Video
Updated: Sep 23, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Network Pharmacology and Bioinformatics Analyses Identify Intersection Genes of Vitamin D3 and COVID-19 as Potential
Shanglin Wang1,2, Huayu Gao3, Xiaoru Wang4
1Research Center of Basic Medicine, Jinan Central Hospital, Shandong University, Jinan, China.
Abstract:
Purpose: The persistent pandemic of coronavirus disease 2019 (COVID-19), the discovery of gastrointestinal transmission routes and the possible susceptibility of cancer patients to COVID-19 have forced us to search for effective pathways against stomach adenocarcinoma (STAD)/COVID-19. Vitamin D3 (VD3) is a steroid hormone with antiviral, anti-inflammatory and immunomodulatory properties. This study aimed to evaluate the possible functional role and potential mechanisms of action of VD3 as an anti-COVID-19 and anti- STAD. Methods: Clinicopathological analysis, enrichment analysis and protein interaction analysis using bioinformatics and network pharmacology methods. Validate the binding activity of VD3 to core pharmacological targets and viral crystal structures using molecular docking. Results: We revealed the clinical characteristics of STAD/COVID-19 patients. We also demonstrated that VD3 may be anti- STAD/COVID-19 through antiviral, anti-inflammatory, and immunomodulatory pathways. Molecular docking results showed that VD3 binds well to the relevant targets of COVID-19, including the spike RBD/ACE2 complex and main protease (Mpro, also known as 3CLpro). We also identified five core pharmacological targets of VD3 in anti-STAD/COVID-19 and validated the binding activity of VD3 to PAI1 by molecular docking. Conclusion: This study reveals for the first time that VD3 may act on disease target gene SERPINE1 through inflammatory and viral related signaling pathways and biological functions for the therapy of STAD/COVID-19. This may provide a new idea for the use of VD3 in the treatment of STAD/COVID-19.
Insights
Vitamin D3 (VD3) shows potential in treating stomach adenocarcinoma (STAD) and COVID-19 by targeting viral and inflammatory pathways. This study explored VD3
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- The COVID-19 pandemic highlights the vulnerability of cancer patients, particularly those with stomach adenocarcinoma (STAD).
- Gastrointestinal transmission routes of SARS-CoV-2 necessitate novel therapeutic strategies.
- Vitamin D3 (VD3) possesses known antiviral, anti-inflammatory, and immunomodulatory properties.
Purpose of the Study:
- To investigate the potential of Vitamin D3 (VD3) as a therapeutic agent against stomach adenocarcinoma (STAD) and COVID-19.
- To elucidate the underlying mechanisms of action for VD3 in combating STAD and COVID-19.
Main Methods:
- Bioinformatics and network pharmacology approaches were employed for clinicopathological and protein interaction analyses.
- Molecular docking was utilized to validate the binding affinity of VD3 to key pharmacological targets and viral proteins.
- Enrichment analysis identified relevant biological pathways and functions.
Main Results:
- Clinical characteristics of STAD/COVID-19 patients were analyzed.
- VD3 demonstrated potential antiviral, anti-inflammatory, and immunomodulatory effects relevant to STAD/COVID-19.
- Molecular docking confirmed VD3 binding to COVID-19 targets (spike RBD/ACE2, Mpro) and identified PAI1 as a core target for anti-STAD/COVID-19 activity.
Conclusions:
- This study suggests VD3 may treat STAD/COVID-19 by targeting the SERPINE1 gene via inflammatory and viral pathways.
- VD3 presents a novel therapeutic avenue for STAD/COVID-19 co-infection.
- Further research into VD3's role in STAD/COVID-19 treatment is warranted.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Microorganisms in Medicine and Therapeutics
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...

